Abstract
Differential Target Multiplexed spinal cord stimulation (DTM™ SCS) is an established therapy that has shown superior back pain relief to traditional SCS.1,2 Derivatives of the DTM waveform are now being investigated to understand opportunities to tailor therapy delivery based on different patient profiles. A recent feasibility study demonstrated patients were able to achieve pain relief and satisfaction with an 82% decrease in charge delivered per second using a reduced-energy DTM SCS derivative.3 This study will provide additional clinical evidence from subjects trialed with reduced-energy DTM as well as 1-, 3-, 6-, and 12-month follow-up outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
